Pterostilbene attenuates the inflammatory reaction induced by ischemia/reperfusion in rat heart

Molecular Medicine Reports

Volumn 11, Issue 1, 2015, Pages 724-728

  Lv, Min ^a   Liu, Kexiang ^b   Fu, Shaopeng ^a   Li, Zhe ^a   Yu, Xia ^c  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^c THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Ischemia reperfusion injury; Neutrophil; Pterostilbene; Tumor necrosis factor

Indexed keywords

CREATINE KINASE; CYCLIC GMP; LACTATE DEHYDROGENASE; METHYLENE BLUE; MYELOPEROXIDASE; N(G) NITROARGININE METHYL ESTER; PTEROSTILBENE; RESVERATROL; STILBENE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CARDIOTONIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDITIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INFLAMMATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; RAT; REPERFUSION INJURY; SHAM PROCEDURE; ANIMAL; BLOOD; DRUG EFFECTS; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY;

RATTUS;

ANIMALS; CARDIOTONIC AGENTS; CREATINE KINASE; INFLAMMATION; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NEUTROPHIL INFILTRATION; RATS; STILBENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84916198334     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2719     Document Type: Article

References (22)

1. Xiong J, Xue FS, Yuan YJ, Wang Q, Liao X and Wang WL: Cholinergic anti-inflammatory pathway: a possible approach to protect against myocardial ischemia reperfusion injury. Chin Med J (Engl) 123: 2720-2726, 2010.
2. Naidu BV, Farivar AS, Woolley SM, Grainger D, Verrier ED and Mulligan MS: Novel broad-spectrum chemokine inhibitor protects against lung ischemia-reperfusion injury. J Heart Lung Transplant 23: 128-134, 2004.
3. Roupe KA, Remsberg CM, Yáñez JA and Davies NM: Pharmacometrics of stilbenes: seguing towards the clinic. Curr Clin Pharmacol 1: 81-101, 2006.
4. Lin HS, Yue BD and Ho PC: Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study. Biomed Chromatogr 23: 1308-1315, 2009.
5. Kapetanovic IM, Muzzio M, Huang Z, Thompson TN and McCormick DL: Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Pharmacol 68: 593-601, 2011.
6. Perecko T, Drabikova K, Rackova L, et al: Molecular targets of the natural antioxidant pterostilbene: effect on protein kinase C, caspase-3 and apoptosis in human neutrophils in vitro. Neuro Endocrinol Lett 31 (Suppl 2): 84-90, 2010.
7. Athar M, Back JH, Tang X, et al: Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 224: 274-283, 2007.
8. McCormack D and McFadden D: A review of pterostilbene antioxidant activity and disease modifcation. Oxid Med Cell Longev 2013: 575482, 2013.
9. McCormack D and McFadden D: Pterostilbene and cancer: current review. J Surg Res 173: e53-e61, 2012.
10. Black SC and Rodger IW: Methods for studying experimental myocardial ischemic and reperfusion injury. J Pharmacol Toxicol Methods 35: 179-190, 1996.
11. Speyer CL and Ward PA: Role of endothelial chemokines and their receptors during infammation. J Invest Surg 24: 18-27, 2011.
12. Khimenko PL, Bagby GJ, Fuseler J and Taylor AE: Tumor necrosis factor-alpha in ischemia and reperfusion injury in rat lungs. J Appl Physiol (1985) 85: 2005-2011, 1998.
13. Batista ML Jr, Rosa JC, Lopes RD, et al: Exercise training changes IL-10/TNF-alpha ratio in the skeletal muscle of post-MI rats. Cytokine 49: 102-108, 2010.
14. Zhu J, Liu M, Kennedy RH and Liu SJ: TNF-alpha-induced impairment of mitochondrial integrity and apoptosis mediated by caspase-8 in adult ventricular myocytes. Cytokine 34: 96-105, 2006.
15. Meldrum DR, Cleveland JC Jr, Cain BS, Meng X and Harken AH: Increased myocardial tumor necrosis factor-alpha in a crystalloid-perfused model of cardiac ischemia-reperfusion injury. Ann Thorac Surg 65: 439-443, 1998.
16. Gurevitch J, Frolkis I, Yuhas Y, et al: Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J Am Coll Cardiol 30: 1554-1561, 1997.
17. Lefer AM, Ma XL, Weyrich A and Lefer DJ: Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury. Agents Actions Suppl 41: 127-135, 1993.
18. Ma XL, Lefer DJ, Lefer AM and Rothlein R: Coronary endo-thelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 86: 937-946, 1992.
19. Chandrasekar B, Smith JB and Freeman GL: Ischemia-reperfusion of rat myocardium activates nuclear factor-KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation 103: 2296-2302, 2001.
20. Liu P, Hock CE, Nagele R and Wong PY: Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol 272: H2327-H2336, 1997.
21. Li J, Wu F, Zhang H, et al: Insulin inhibits leukocyte-endothelium adherence via an Akt-NO-dependent mechanism in myocardial ischemia/reperfusion. J Mol Cell Cardiol 47: 512-519, 2009.
22. Li J, Zhang H, Wu F, et al: Insulin inhibits tumor necrosis factor-alpha induction in myocardial ischemia/reperfusion: role of Akt and endothelial nitric oxide synthase phosphorylation. Crit Care Med 36: 1551-1558, 2008.